‘Bidirectional’ patient transfers helped this state protect rural healthcare from COVID

A Western U.S. state may have rescued its rural hospitals from potential financial ruin at the hands of the pandemic. In the process the state has set the bar for regional health networks facing similar threats around the country.

The Colorado Hospital Association’s VP of rural health and hospitals tells the story to the ABC affiliate in Denver via TheDenverChannel.com.

The state’s key move was making the expected rural-to-urban patient transfers a “two-way highway,” explains the VP, Benjamin Anderson.

As the COVID crisis raged during its second spike, he says, “urban patients were being shipped in certain crisis points out to rural hospitals, where they would get optimal care” thanks to a well-coordinated effort to ready the rurals to handle nonemergency demand.

Other decisive actions included cross-training staff on urban- and rural-specific routines, leveraging loans from the federal Paycheck Protection Program and marshaling the will to work with unfamiliar colleagues on a broad scale.

“There’s been statewide collaboration,” Anderson tells the outlet. “[R]ural and urban hospitals and health systems voluntarily collaborated to set up this model that would allow for efficient, reliable transfer of patients” in both directions along the aforementioned two-way highway.

In both settings, he adds, “turning people away from care was not acceptable to us.”

Denver Channel coverage here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.